OncoTherapy Science, Inc.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2026 is -15.24% vs 100.10% in Jun 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2026 is 8.11% vs -4.00% in Jun 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "170.80",
          "val2": "201.50",
          "chgp": "-15.24%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-285.10",
          "val2": "-303.90",
          "chgp": "6.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.30",
          "val2": "0.30",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.80",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-288.90",
          "val2": "-314.40",
          "chgp": "8.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1,669.80%",
          "val2": "-1,508.40%",
          "chgp": "-16.14%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 7.80% vs 22.93% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is -11.69% vs 36.71% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "808.50",
          "val2": "750.00",
          "chgp": "7.80%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-810.40",
          "val2": "-797.90",
          "chgp": "-1.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.30",
          "val2": "1.20",
          "chgp": "8.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-62.70",
          "val2": "1.90",
          "chgp": "-3,400.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-910.60",
          "val2": "-815.30",
          "chgp": "-11.69%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1,002.30%",
          "val2": "-1,063.80%",
          "chgp": "6.15%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'26 - YoY

Jun'26

Jun'25

Change(%)

Net Sales

170.80

201.50

-15.24%

Operating Profit (PBDIT) excl Other Income

-285.10

-303.90

6.19%

Interest

0.30

0.30

Exceptional Items

-0.80

0.00

Consolidate Net Profit

-288.90

-314.40

8.11%

Operating Profit Margin (Excl OI)

-1,669.80%

-1,508.40%

-16.14%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2026 is -15.24% vs 100.10% in Jun 2025

Consolidated Net Profit

YoY Growth in quarter ended Jun 2026 is 8.11% vs -4.00% in Jun 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'26

Mar'26

Mar'25

Change(%)

Net Sales

808.50

750.00

7.80%

Operating Profit (PBDIT) excl Other Income

-810.40

-797.90

-1.57%

Interest

1.30

1.20

8.33%

Exceptional Items

-62.70

1.90

-3,400.00%

Consolidate Net Profit

-910.60

-815.30

-11.69%

Operating Profit Margin (Excl OI)

-1,002.30%

-1,063.80%

6.15%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2026 is 7.80% vs 22.93% in Mar 2025

Consolidated Net Profit

YoY Growth in year ended Mar 2026 is -11.69% vs 36.71% in Mar 2025

All Annual Results